Neurology 4-Plex A (NF-light®, Tau, GFAP*, UCHL-1*)

Neurology 4-Plex A (NF-light®, Tau, GFAP*, UCHL-1*)

The Simoa Human Neurology 4-Plex A assay (N4PA) measures four important neurology biomarkers in both cerebrospinal fluid (CSF) and blood. The four targets are neurofilament light (NF-L), total tau, glial fibrillary acidic protein (GFAP), and ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1). All four biomarkers have been studied as indicators of traumatic brain injury (TBI) severity. Recent reports indicate serum NF-L is a biomarker for mild TBI in amateur boxers and professional hockey players, that plasma tau is related to concussion severity, and that serum GFAP and UCH-L1 can detect mild to moderate TBI.

*Banyan UCH-L1™ and Banyan GFAP™ are registered trademarks of Banyan Biomarkers


Safety Data Sheets

The following Safety Data Sheets are associated with this Assay.

This website uses cookies. By continuing to use this website you are acknowledging and agree with our cookie policy.

AgreeLearn more